1. Home
  2. BOLD vs FPAY Comparison

BOLD vs FPAY Comparison

Compare BOLD & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • FPAY
  • Stock Information
  • Founded
  • BOLD 2018
  • FPAY 2003
  • Country
  • BOLD United States
  • FPAY United States
  • Employees
  • BOLD N/A
  • FPAY N/A
  • Industry
  • BOLD
  • FPAY Diversified Commercial Services
  • Sector
  • BOLD
  • FPAY Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • BOLD 30.3M
  • FPAY 28.7M
  • IPO Year
  • BOLD 2024
  • FPAY N/A
  • Fundamental
  • Price
  • BOLD $1.13
  • FPAY $1.43
  • Analyst Decision
  • BOLD Buy
  • FPAY Strong Buy
  • Analyst Count
  • BOLD 3
  • FPAY 2
  • Target Price
  • BOLD $4.00
  • FPAY $3.25
  • AVG Volume (30 Days)
  • BOLD 79.0K
  • FPAY 44.4K
  • Earning Date
  • BOLD 05-09-2025
  • FPAY 06-10-2025
  • Dividend Yield
  • BOLD N/A
  • FPAY N/A
  • EPS Growth
  • BOLD N/A
  • FPAY N/A
  • EPS
  • BOLD N/A
  • FPAY N/A
  • Revenue
  • BOLD N/A
  • FPAY $139,800,732.00
  • Revenue This Year
  • BOLD N/A
  • FPAY $16.58
  • Revenue Next Year
  • BOLD N/A
  • FPAY N/A
  • P/E Ratio
  • BOLD N/A
  • FPAY N/A
  • Revenue Growth
  • BOLD N/A
  • FPAY 19.51
  • 52 Week Low
  • BOLD $1.06
  • FPAY $0.97
  • 52 Week High
  • BOLD $10.13
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • FPAY 60.98
  • Support Level
  • BOLD N/A
  • FPAY $1.15
  • Resistance Level
  • BOLD N/A
  • FPAY $1.44
  • Average True Range (ATR)
  • BOLD 0.00
  • FPAY 0.08
  • MACD
  • BOLD 0.00
  • FPAY 0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • FPAY 96.55

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: